08:00 , Feb 18, 2008 |  BC Week In Review  |  Company News

BBI Holdings, Inverness deal

Inverness completed its previously announced acquisition of the 88% of BBI Holdings it did not already own for about £63.2 million ($123 million) in cash and about $11.2 million in stock (see BioCentury, Dec. 17,...
08:00 , Dec 17, 2007 |  BC Week In Review  |  Company News

BBI Holdings, Inverness deal

Diagnostic company IMA will acquire the 88% of BBI it does not already own for cash or stock. BBI shareholders may receive either £1.95 per share in IMA stock, for a total of £73.5 million...
07:00 , Apr 2, 2007 |  BC Week In Review  |  Company News

BBI Holdings, Theratase deal

BBI will acquire THE for 10.6 million shares and £7.6 million ($14.9 million) in cash. Based on BBI’s close of 146p on March 26, the last trading day before the deal was announced, the total...
07:00 , Sep 26, 2005 |  BC Week In Review  |  Company News

BBI Holdings, Pharmacia Diagnostics AB deal

BBI will manufacture Pharmacia's ImmunoCAP Rapid diagnostic allergy tests. The tests will initially be marketed in Spain, Denmark, Sweden and Switzerland. BBI Holdings plc (LSE:BBI), Cardiff, U.K.   Pharmacia Diagnostics AB , Uppsala, Sweden  ...
07:00 , Aug 1, 2005 |  BC Week In Review  |  Company News

BBI Holdings, Talecris deal

The companies partnered to develop a test that screens patients for alpha-1 antitrypsin (AAT) deficiency. Talecris will fund the research. BBI Holdings plc (LSE:BBI), Cardiff, U.K.   Talecris Biotherapeutics Inc. , Research Triangle Park, N.C....